Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology.
about
Risperidone for autism spectrum disorderSystematic review of the properties of tools used to measure outcomes in anxiety intervention studies for children with autism spectrum disordersParvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits.Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability.Cognitive effects of risperidone in children with autism and irritable behavior.Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trialOutcome measures for clinical drug trials in autism.Developmental disabilities modification of the Children's Global Assessment ScaleTolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.Improving Treatment Trial Outcomes for Rett Syndrome: The Development of Rett-specific Anchors for the Clinical Global Impression ScaleSystematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders.Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders.Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptomsMeasuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder.Outcome measures in intervention trials for adults with autism spectrum disorders; a systematic review of assessments of core autism features and associated emotional and behavioural problems.What happens to children with PDD when they grow up? Prospective follow-up of 219 children from preschool age to mid-childhood.Psychotropic drug treatments for people with autism and other developmental disorders: a primer for practicing behavior analystsAn Initial Psychometric Evaluation of the Joint Attention Protocol.Paliperidone for irritability in adolescents and young adults with autistic disorder.Evidence for linkage on chromosome 3q25-27 in a large autism extended pedigree.Brief report: "Quick and (not so) dirty" assessment of change in autism: cross-cultural reliability of the Developmental Disabilities CGAS and the OSU autism CGI.
P2860
Q24246471-2EF76636-0152-47FA-86DE-19420319E5C9Q27023264-1B8F4C3B-3715-41D7-822A-2F2579E968E3Q30578270-72D62536-FE09-4446-8DB4-207C5AA3F101Q33832125-30A09F41-301E-442F-9F44-58FF4A9164EAQ34112075-2F08C1CA-089A-41D2-91E1-61CD0A6FA5D7Q35125984-B0EA0A5A-3C9B-4431-A1C8-F423410B1421Q35636181-DC4923A6-2A7A-4D97-B108-D038B71EC05BQ35946655-16FE1F0A-A574-4EF5-BB08-375EA5CEFEBDQ35985482-5915C7BB-2597-4FA0-BA24-EFF3D35A6B63Q36176918-908983A6-2E94-43A4-8E14-A507E9C078C7Q36258557-A9009F4D-61BD-43FC-AB92-5430D115BE00Q36880820-3ED5471C-2C6B-49A2-9C70-7AF53D82C455Q36947682-1C522138-368C-4DD3-A6CE-0D6BA2B35577Q38164696-6C68537C-3CE0-4B5E-82DA-88E8B1515C60Q38528316-F5966AED-889D-454A-9768-DC3BACC64CB2Q40223912-D3A165DB-4DC4-4C84-8F32-98EA499553C9Q41247017-F3910B11-2DDA-40E4-AC9E-44D28711FB15Q47201517-01D5B843-B091-49AD-B76B-5F8476C1F297Q47291177-8986BDC3-8D31-4AD3-A32C-C9D0090195F9Q50304901-9AF0407B-4E73-4D12-96CC-FD1A8ED8D25BQ50345122-A66ACCCE-DD3A-4256-AD5F-EB6631472D91
P2860
Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Assessment in multisite random ...... Pediatric Psychopharmacology.
@ast
Assessment in multisite random ...... Pediatric Psychopharmacology.
@en
type
label
Assessment in multisite random ...... Pediatric Psychopharmacology.
@ast
Assessment in multisite random ...... Pediatric Psychopharmacology.
@en
prefLabel
Assessment in multisite random ...... Pediatric Psychopharmacology.
@ast
Assessment in multisite random ...... Pediatric Psychopharmacology.
@en
P2093
P356
P1476
Assessment in multisite random ...... Pediatric Psychopharmacology.
@en
P2093
Bell-Bradshaw F
Collier-Crespin A
Freeman BJ
Gates-Ulanet P
McCracken JT
McDougle CJ
P2888
P304
P356
10.1023/A:1005451304303
P407
P577
2000-04-01T00:00:00Z
P6179
1050381228